Image source: Getty Images.

The annual J.P. Morgan Healthcare Conference, often called the Superbowl of biotech, kicked off on January 9, 2017.

The Motley Fool has you covered with reports on company presentations and themes from the conference. Check back daily for updates!

PS -- if you're interested in checking out how much things have changed since this time in 2016, here's last year's landing page.

The Motley Fool owns shares of and recommends Celgene, Gilead Sciences, Illumina, Ionis Pharmaceuticals, and Valeant Pharmaceuticals. The Motley Fool recommends Johnson and Johnson and Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.